Literature DB >> 26975726

Familial associations of monoclonal gammopathy of unknown significance with autoimmune diseases.

K Hemminki1,2, A Försti1,2, K Sundquist2,3, J Sundquist2,3, X Li2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26975726     DOI： 10.1038/leu.2016.43

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study.

Authors:  Angela Dispenzieri; Jerry A Katzmann; Robert A Kyle; Dirk R Larson; L Joseph Melton; Colin L Colby; Terry M Therneau; Raynell Clark; Shaji K Kumar; Arthur Bradwell; Rafael Fonseca; D F Jelinek; S Vincent Rajkumar
Journal:  Lancet       Date:  2010-05-15       Impact factor: 79.321

2.  Familial association of inflammatory bowel diseases with other autoimmune and related diseases.

Authors:  Kari Hemminki; Xinjun Li; Kristina Sundquist; Jan Sundquist
Journal:  Am J Gastroenterol       Date:  2009-08-25       Impact factor: 10.864

3.  Inherited genetic susceptibility to monoclonal gammopathy of unknown significance.

Authors:  Niels Weinhold; David C Johnson; Andrew C Rawstron; Asta Försti; Chi Doughty; Jayaram Vijayakrishnan; Peter Broderick; Nasrin B Dahir; Dil B Begum; Fay J Hosking; Kwee Yong; Brian A Walker; Per Hoffmann; Thomas W Mühleisen; Christian Langer; Elisabeth Dörner; Karl-Heinz Jöckel; Lewin Eisele; Markus M Nöthen; Dirk Hose; Faith E Davies; Hartmut Goldschmidt; Gareth J Morgan; Kari Hemminki; Richard S Houlston
Journal:  Blood       Date:  2014-01-21       Impact factor: 22.113

4.  Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study.

Authors:  Sigurdur Y Kristinsson; Min Tang; Ruth M Pfeiffer; Magnus Björkholm; Lynn R Goldin; Cecilie Blimark; Ulf-Henrik Mellqvist; Anders Wahlin; Ingemar Turesson; Ola Landgren
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

5.  Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS).

Authors:  Sham Mailankody; Ruth M Pfeiffer; Sigurdur Y Kristinsson; Neha Korde; Magnus Bjorkholm; Lynn R Goldin; Ingemar Turesson; Ola Landgren
Journal:  Blood       Date:  2011-07-27       Impact factor: 22.113

6.  Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study.

Authors:  Ebba K Lindqvist; Lynn R Goldin; Ola Landgren; Cecilie Blimark; Ulf-Henrik Mellqvist; Ingemar Turesson; Anders Wahlin; Magnus Björkholm; Sigurdur Y Kristinsson
Journal:  Blood       Date:  2011-10-13       Impact factor: 22.113

Review 7.  Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.

Authors:  R A Kyle; B G M Durie; S V Rajkumar; O Landgren; J Blade; G Merlini; N Kröger; H Einsele; D H Vesole; M Dimopoulos; J San Miguel; H Avet-Loiseau; R Hajek; W M Chen; K C Anderson; H Ludwig; P Sonneveld; S Pavlovsky; A Palumbo; P G Richardson; B Barlogie; P Greipp; R Vescio; I Turesson; J Westin; M Boccadoro
Journal:  Leukemia       Date:  2010-04-22       Impact factor: 11.528

8.  Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.

Authors:  Celine M Vachon; Robert A Kyle; Terry M Therneau; Barbara J Foreman; Dirk R Larson; Colin L Colby; Tara K Phelps; Angela Dispenzieri; Shaji K Kumar; Jerry A Katzmann; S Vincent Rajkumar
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

9.  Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study.

Authors:  Sigurdur Y Kristinsson; Magnus Björkholm; Therese M-L Andersson; Sandra Eloranta; Paul W Dickman; Lynn R Goldin; Cecilie Blimark; Ulf-Henrik Mellqvist; Anders Wahlin; Ingemar Turesson; Ola Landgren
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

10.  Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort Study.

Authors:  Ola Landgren; Youn K Shim; Joel Michalek; Rene Costello; Debra Burton; Norma Ketchum; Katherine R Calvo; Neil Caporaso; Elizabeth Raveche; Dan Middleton; Gerald Marti; Robert F Vogt
Journal:  JAMA Oncol       Date:  2015-11       Impact factor: 31.777
View more
  5 in total

1.  Familial associations for rheumatoid autoimmune diseases.

Authors:  Hauke Thomsen; Xinjun Li; Kristina Sundquist; Jan Sundquist; Asta Försti; Kari Hemminki
Journal:  Rheumatol Adv Pract       Date:  2020-09-22

Review 2.  Lessons Learned from Checkpoint Blockade Targeting PD-1 in Multiple Myeloma.

Authors:  Alexander M Lesokhin; Susan Bal; Ashraf Z Badros
Journal:  Cancer Immunol Res       Date:  2019-08       Impact factor: 11.151

3.  Familial associations of lymphoma and myeloma with autoimmune diseases.

Authors:  K Hemminki; A Försti; K Sundquist; J Sundquist; X Li
Journal:  Blood Cancer J       Date:  2017-01-06       Impact factor: 11.037

4.  Familial risks between giant cell arteritis and Takayasu arteritis and other autoimmune diseases in the population of Sweden.

Authors:  Hauke Thomsen; Xinjun Li; Kristina Sundquist; Jan Sundquist; Asta Försti; Kari Hemminki
Journal:  Sci Rep       Date:  2020-11-30       Impact factor: 4.379

5.  Familial associations for Addison's disease and between Addison's disease and other autoimmune diseases.

Authors:  Hauke Thomsen; Xinjun Li; Kristina Sundquist; Jan Sundquist; Asta Försti; Kari Hemminki
Journal:  Endocr Connect       Date:  2020-11       Impact factor: 3.335
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.